Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase

Author： Pönitz Volker Pritchard David Grundt Heidi Nilsen Dennis

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.22, Iss.3, 2006-12, pp. : 199-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome

Cerebrovascular Diseases, Vol. 42, Iss. 5-6, 2016-07 ,pp. : 404-414

Karger

Access to resources Recommend Favorite

Thrombolytic therapy in pregnancy

By Leonhardt Georg Gaul Charly Nietsch Hubert Buerke Michael Schleussner Ekkehard

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 271-276

Springer Publishing Company

Access to resources Recommend Favorite

Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors

Cerebrovascular Diseases, Vol. 24, Iss. 1, 2007-05 ,pp. : 1-10

Karger

Access to resources Recommend Favorite

Streptokinase—the drug of choice for thrombolytic therapy

By Kunamneni Adinarayana Abdelghani Thaer Ellaiah Poluri

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 1, 2007-02 ,pp. : 9-23

Springer Publishing Company

Access to resources Recommend Favorite

Thrombolytic Therapy in Acute Ischaemic Stroke

Cerebrovascular Diseases, Vol. 13, Iss. 3, 2002-03 ,pp. : 163-167

Karger

Access to resources Recommend Favorite